Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 13
Submit an article Journal homepage
497
Views
9
CrossRef citations to date
0
Altmetric
Letters to the Editor

Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in TET2, DNMT3 and CUX1 – azacitidine induces only lymphoma remission

Magnus TobiassonDepartment of Hematology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-3633-5852
ORCID Icon,
Tatjana PandzicDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;
,
Lucia CavelierDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;
,
Birgitta SanderDepartment of Laboratory Medicine, Division of Pathology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
&
Björn Engelbrekt WahlinDepartment of Hematology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden;
Pages 3316-3319 | Received 11 Mar 2019, Accepted 26 May 2019, Published online: 17 Jun 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Martin Jädersten, Ksenia Boriskina, Carolin Lindholm, Simone Weström, Lucia Cavelier, Eva Hellström-Lindberg, Stephan Mielke & Magnus Tobiasson. (2022) Limited benefit in patients with MDS receiving venetoclax and azacitidine as a bridge to allogeneic stem cell transplantation. Leukemia & Lymphoma 63:3, pages 755-758.
Read now

Articles from other publishers (8)

Sang Eun Yoon, Junhun Cho, Yeon Jeong Kim, Seok Jin Kim & Won Seog Kim. (2022) Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 22:11, pages e972-e980.
Crossref
Suheil Albert Atallah-Yunes, Michael J. Robertson & Utpal P. Davé. (2022) Epigenetic Aberrations and Targets in Peripheral T-Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 22:9, pages 659-665.
Crossref
Kyoko Yoshihara, Yasuhito Nannya, Ikuo Matsuda, Mami Samori, Nobuto Utsunomiya, Masaya Okada, Seiichi Hirota, Seishi Ogawa & Satoshi Yoshihara. (2021) T‐cell lymphoma, B‐cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone. eJHaem 3:1, pages 211-214.
Crossref
Zachary D. Epstein-Peterson & Steven M. Horwitz. (2021) Molecularly targeted therapies for relapsed and refractory peripheral T-cell lymphomas. Seminars in Hematology 58:2, pages 78-84.
Crossref
Monika Klimkowska, Yasuhito NannyaCharlotte GranRobert Månsson, Iyadh DouagiSeishi Ogawa, Hareth Nahi & Magnus Tobiasson. (2021) Absence of a common founder mutation in patients with cooccurring myelodysplastic syndrome and plasma cell disorder. Blood 137:9, pages 1260-1263.
Crossref
. (2020) Methotrexate. Reactions Weekly 1828:1, pages 313-313.
Crossref
Natasha E. Lewis, Kseniya Petrova-Drus, Sarah HuetZachary D. Epstein-PetersonQi GaoAllison E. SiglerJeeyeon BaikNeval OzkayaAlison J. MoskowitzAnita KumarSteven M. HorwitzYanming ZhangMaria E. ArcilaRoss L. Levine, Mikhail RoshalAhmet Dogan & Wenbin Xiao. (2020) Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms. Blood Advances 4:10, pages 2261-2271.
Crossref
Cheryl Foster & John Kuruvilla. (2020) Treatment approaches in relapsed or refractory peripheral T-cell lymphomas. F1000Research 9, pages 1091.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.